Loading company details...
Latest Form 4 (Oct 23, 2026): Kelly Blackburn (EVP, Clinical Development): Grant/Award of 19,100 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 23, 2026 | Kelly Blackburn, EVP, Clinical Development | Grant/Award | 19,100 | n/a |
| Oct 23, 2026 | Rosch Mark De, EVP, RA and GA and PgM | Grant/Award | 19,100 | n/a |
| Oct 23, 2026 | Matthew Winton, Chief Commercial and Business | Grant/Award | 19,100 | n/a |
| Jun 15, 2026 | Joshua S. Boger | Purchase | 955,414 | $3.00M |
| Jun 10, 2026 | Frank Zavrl | Grant/Award | 8,150 | n/a |
| Jun 10, 2026 | Marwan Sabbagh | Grant/Award | 8,150 | n/a |
| Jun 10, 2026 | David Quigley | Grant/Award | 8,150 | n/a |
| Jun 10, 2026 | Jeffrey Poulton V. | Grant/Award | 8,150 | n/a |
| Jun 10, 2026 | Jane H. Hollingsworth | Grant/Award | 8,150 | n/a |
| Jun 10, 2026 | Sylvie Gregoire | Grant/Award | 8,150 | n/a |